Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine

https://investors.amyris.com/2020-10-22-Amyris-and-The-Infectious-Disease-Research-Institute-Enter-into-Exclusive-License-for-Novel-RNA-Vaccine-Platform-Beginning-with-COVID-19-Vaccine
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.